Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study

BACKGROUND: Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs) promise clearance of infection in most of patients. Here we present the results of the first analysis carried out on data of Lazio cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanini, Simone, Scognamiglio, Paola, Mecozzi, Alessandra, Lombardozzi, Lorella, Vullo, Vincenzo, Angelico, Mario, Gasbarrini, Antonio, Taliani, Gloria, Attili, Adolfo Francesco, Perno, Carlo Federico, De Santis, Adriano, Puro, Vincenzo, Cerqua, Fabio, D’Offizi, Gianpiero, Pellicelli, Adriano, Armignacco, Orlando, Mennini, Francesco Saverio, Siciliano, Massimo, Girardi, Enrico, Panella, Vincenzo, Ippolito, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956792/
https://www.ncbi.nlm.nih.gov/pubmed/29769038
http://dx.doi.org/10.1186/s12879-018-3125-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956792/
https://www.ncbi.nlm.nih.gov/pubmed/29769038
http://dx.doi.org/10.1186/s12879-018-3125-6

Ejemplares similares